Richard John Holl

Title: Richard John Holl: Innovator in Pharmaceutical Treatments

Introduction

Richard John Holl is a notable inventor based in Somerset, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of trichomoniasis and bacterial vaginosis. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Holl's latest patents include a method and pharmaceutical composition for treating or preventing trichomoniasis. This method involves administering a therapeutically effective amount of secnidazole or a pharmaceutically acceptable salt in a microgranule formulation. The formulation is designed for subjects who may also have bacterial vaginosis, are HIV-positive, or are suffering from metronidazole-resistant trichomoniasis. Additionally, he has developed a patent for deuterated secnidazole, which is aimed at treating bacterial vaginosis or trichomoniasis in subjects in need. This invention also encompasses pharmaceutical compositions and methods for treating various infections.

Career Highlights

Richard John Holl is currently associated with Evofem Biosciences, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a focus on effective treatments for complex infections, showcasing his commitment to improving patient outcomes.

Collaborations

Holl has collaborated with notable colleagues such as Helen S Pentikis and Gregory Kaufman. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Richard John Holl stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative treatments for trichomoniasis and bacterial vaginosis. His contributions are paving the way for improved healthcare solutions.